Bryn Pharma is creating a new solution to help people with anaphylaxis shock, and the founders Steven Hartman and Michelle Lobel suffer from anaphylaxis shock as well. Bryn Pharma raised $17.5M from investors that include family offices and private investors, as well as $2.5M in a corporate collaborator. Bryn Pharma has reportedly raised a total of $44M across three rounds.
The TechWatch Media Group audience is driving progress and innovation on a global scale. TechWatch Media is the highway for technology and entrepreneurship. There are a number of options to reach this audience of the world’s most innovative organizations and startups at scale including sponsoring a report like this. Find out more here.
Page 2 of 9
